A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care
Conditions: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Other Cancer Interventions: Behavioral: Complement Theory ' s Live 1:1 Exercise Coaching and Personalized Digital Application; Behavioral: Digital application with expert guidelines on lifestyle modification Sponsors: Complement Theory Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2024 Category: Research Source Type: clinical trials
Proof-of-Concept Study Evaluating an Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity
Conditions: Breast Cancer Interventions: Behavioral: Weight Loss Sponsors: University of Colorado, Denver; National Cancer Institute (NCI); National Insitutes of Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2024 Category: Research Source Type: clinical trials
Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam
Conditions: Breast Cancer; Gynecologic Cancer Interventions: Behavioral: Vietnamese Self-Help Plus (vSH+); Other: ' Doing What Matters in Times of Stress ' (DWM) Guide Sponsors: Boston University; Fogarty International Center of the National Institute of Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2024 Category: Research Source Type: clinical trials
Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC
Conditions: Triple Negative Breast Cancer Interventions: Other: AI-analysis on diagnostic and surgical specimens Sponsors: Institute of Cancer Research, United Kingdom; Case45 Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2024 Category: Research Source Type: clinical trials
The Effect of Breast Cancer Prevention Journey Program
Conditions: Breast Cancer Female Interventions: Other: Breast Cancer Prevention Journey Program Group; Other: Routine Cancer Screening Program Group Sponsors: Nurbanu Odac ı; The Scientific and Technological Research Council of Turkey Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2024 Category: Research Source Type: clinical trials
Thrive well cancer fdtn/exercise_creatine supplementation
Conditions: Breast Cancer; Breast Cancer Female; Muscle Weakness Interventions: Dietary Supplement: Creatine Sponsors: The University of Texas Medical Branch, Galveston; ThriveWell Cancer Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2024 Category: Research Source Type: clinical trials
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Conditions: Advanced or Metastatic Solid Tumors; Breast Cancer; Ovarian Cancer; Prostate Cancer; Epithelial Ovarian Cancer; BRCA2 Mutation; ER+ Breast Cancer; Castrate Resistant Prostate Cancer; BRCA1 Mutation; BRCA Mutation; Endometrial Cancer; Colorectal Cancer; Gastric Cancer Interventions: Drug: ETX-19477 Sponsors: 858 Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2024 Category: Research Source Type: clinical trials
Serplulimab Plus Chemotherapy for Early-stage ER+/HER2- Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Serplulimab Sponsors: Henan Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR
Conditions: Triple-Negative Breast Cancer Interventions: Biological: Pembrolizumab; Biological: sac-TMT; Drug: Capecitabine Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Label-free Raman Spectroscopy for Discrimination Between Breast Cancer Tumor and Adjacent Tissues After Neoadjuvant Treatment
Conditions: Diagnosis Interventions: Diagnostic Test: Diagnostic Test Sponsors: RenJi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
Conditions: Cancer Colon; Cancer, Liver; Cancer, Lung; Cancer, Breast; Cancer, Gastric Sponsors: Gene Solutions; University of Medicine and Pharmacy at Ho Chi Minh City Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Avidin-biotin-Dota-90Y Sponsors: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases
Conditions: Breast Cancer; Bone Metastases Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Insomnia Interventions: Behavioral: Cognitive Behavior Therapy for Insomnia; Other: Internet-Based Intervention; Other: Medical Device Usage and Evaluation; Other: Questionnaire Administration; Other: Text Message-Based Navigation Intervention Sponsors: University of Washington; The Hope Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
Conditions: TNBC - Triple-Negative Breast Cancer Interventions: Drug: LM-108; Drug: Toripalimab; Drug: Eribulin; Drug: Nab paclitaxel Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2024 Category: Research Source Type: clinical trials
